Big Pharma Split Corp.
$100,000,000.00
4,000,000.00 Common Shares at $15.00
Initial Public Offering - Closed - Friday, November 24, 2017
Company Description
Big Pharma Split Corp. is a mutual fund corporation created to invest in an initially equally-weighted portfolio comprised of equity securities of ten issuers, selected by the Portfolio Manager from the Investable Universe, that at the time of investment and immediately following each semi-annual reconstitution and rebalancing: (i) are listed on a North American exchange; (ii) pay a dividend; and (iii) have options in respect of its Equity Securities. The portfolio will be comprised primarily of the largest pharmaceutical Issuers in the Investable Universe. Harvest Portfolios Group Inc. will act as the manager, portfolio manager and promoter of the Company and will provide all administrative services required by the Company.
| Address: |
710 Dorval Drive, Suite 209 Oakville, Ontario, L6K 3V7 Canada |
|---|---|
| Phone Number: | 416 649 4541 |
| Fax Number: | 416 649 4542 |
| Website: |
| Industry: | Financial & Investment Services |
|---|---|
| Closing Date: | Friday, November 24, 2017 |
| 1st Day of Trading: | Friday, November 24, 2017 |
| Primary Symbol: | PRM |
| Exchange: | Toronto |
Proceeds
The net procees of the offering will be used to purchase the securities for the portfolio.
| Gross Proceeds: | $100,000,000.00 |
|---|---|
| Underwrting Fees: | $4,200,000.00 |
| Expense Offering: | $600,000.00 |
| Net Proceeds: | $95,200,000.00 |
| Lead Underwriter: | BMO Nesbitt Burns Inc. |
|---|---|
| Other Underwriter(s): |
CIBC World Markets Inc. Scotia Capital Inc. National Bank Financial Inc. Desjardins Securities Inc. GMP Securities Ltd. Raymond James Ltd. Industrial Alliance Securities Inc. Canaccord Genuity Corp. PI Financial Corp. Mackie Research Capital Corporation Echelon Wealth Partners Inc. |
Performance
| 1 day | 1 week | 1 month | 6 months | Inception | |
|---|---|---|---|---|---|
| Recent Performance | -0.77 % | 0.96 % | 2.11 % | -12.97 % | -22.60 % |
| Post IPO Performance | -3.33 % | -3.33 % | -16.53 % |
The content of this page is transmitted strictly for informational purposes. Investments must be selected in accordance with the investor's respective objectives. Desjardins Online Brokerage does not issue any recommendations or endorsements concerning any particular product, its potential value or appropriateness, or any specific strategy. It is highly recommended to read the prospectus before making any type of investment.